About: 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 2000 (uk) im Oktober 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 2000 (ast) scientific article published on 01 October 2000 (en)
publication date	wds:Q73080412-64B70B41-991A-4FE5-8139-6750FA115061
publication date	2000-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73080412-B7B5BD7E-1120-4766-9D14-7BE143D01038
language of work or name	English
author name string	wds:Q73080412-4C3C0868-077E-4DE6-8F9C-09128BC19CB9 wds:Q73080412-4C466599-00A4-4954-ABF6-5E39E02AE50D wds:Q73080412-4FECBAC1-6DEC-40BF-ABA6-065DDA1093C7 wds:Q73080412-61296879-4181-421B-AD89-D00298C607DE wds:Q73080412-6141B052-C1E5-4C00-A8BA-4B33C1FDC589 wds:Q73080412-81805D94-485E-402D-8031-540A851889FF wds:Q73080412-8E7C1CD4-DCC8-46F7-BD54-2BE9CDF5F952 wds:Q73080412-B4300C22-435E-4B59-803D-184FE10B1E6F wds:Q73080412-BB70555C-B0E6-4260-AECF-440B2FCEF4D2 wds:Q73080412-D41C9913-F57A-4E7A-9B25-900AC585A4F7 wds:Q73080412-D5DD8373-74F4-4BD0-ABD2-D385BC1E1F26 wds:Q73080412-E247580B-5E05-4F37-9256-89D1309583C7 wds:Q73080412-E9B6B411-CAA6-40E6-865B-8221E26F895B wds:Q73080412-FF52E60A-9D9D-4C31-855C-85EA336CE023
author name string	G Somlo American Society of Clinical Oncology P A Pizzo J Crawford C A Schiffer H Ozer J O Armitage C L Bennett J C Wade G D Demetri M R Somerfield J L Wade R J Winn A J Wozniak
rdfs:label	2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel (en) 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel (nl)
skos:prefLabel	2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel (en) 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel (nl)
name	2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel (en) 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel (nl)
author	wds:Q73080412-EA1D644E-3C69-4CC5-8FCF-CA45CE246D77
author	Thomas J. Smith
title	wds:Q73080412-ED4CAEBF-BD81-4022-93F8-07D0278D0475
title	2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel (en)
page(s)	wds:Q73080412-F8D28B8E-5168-4375-BB8D-3D48501A4F17
page(s)	3558-3585
instance of	wds:Q73080412-0F7548AD-9ECC-4A63-A7B5-FBC7CD8706BB
instance of	scholarly article
main subject	wds:Q73080412-ABC0DE8A-FD11-4D66-A74C-0E9322630D40
main subject	clinical oncology
PubMed ID	wds:Q73080412-C48D4355-1DA9-4714-9273-E142D297571C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11032599
PubMed ID	11032599
published in	wds:Q73080412-01B9C7F3-C29E-498B-9EC1-A100DD11BF2A
published in	Journal of Clinical Oncology
issue	wds:Q73080412-B836C2CC-E040-47A1-8C7B-567314A4149B
volume	wds:Q73080412-5850E8B7-55AC-49DD-B6E5-8B65CC6B2E74
issue	20
volume	18
DOI	wds:Q73080412-C59733F2-BD19-4388-B6E8-96FB9FE33210
DOI	http://dx.doi.org/10.1200/JCO.2000.18.20.3558
DOI	10.1200/JCO.2000.18.20.3558
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73080412
is cites work of	Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma PointBreak: a randomized phase III study of pemetrexed plus carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and bevacizumab followed by maintenance bevacizumab in patients with stage Mobilizing potential of ifosfamide/vinorelbine-based chemotherapy in pretreated malignant lymphoma Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines Management of chemotherapy-induced adverse effects in the treatment of colorectal cancer Medical visits for chemotherapy and chemotherapy-induced neutropenia: a survey of the impact on patient time and activities Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management G-CSF and GM-CSF in Neutropenia Breast carcinoma during pregnancy. International recommendations from an expert meeting Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia Dexrazoxane for anthracycline extravasation and GM-CSF for skin ulceration and wound healing A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics Current and future use of hematopoietic growth factors in cancer medicine Clinical pharmacokinetics of docetaxel : recent developments Effect of neutropenia on the impact of a cognitive-behavioral intervention for symptom management Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer Phase I trial of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with thoracic malignancies A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube. The taxanes: toxicity and quality of life considerations in advanced ovarian cancer Clinical applications of granulocyte colony-stimulating factor: an update and summary Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group Biosimilars in the management of neutropenia: focus on filgrastim Colony-stimulating factors: clinical evidence for treatment and prophylaxis of chemotherapy-induced febrile neutropenia The safety of full-dose chemotherapy with secondary prophylactic granulocyte colony stimulating factor (G-CSF) following a prior cycle with febrile neutropenia Treatment of periodontal disease in the immunodeficient patient Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urothelium Activity of second-line chemotherapy in docetaxel-refractory hormone-refractory prostate cancer patients : randomized phase 2 study of ixabepilone or mitoxantrone and prednisone. Colony stimulating factors for chemotherapy induced febrile neutropenia Guideline-Based Peer-to-Peer Consultation Optimizes Pegfilgrastim Use With No Adverse Clinical Consequences Deviations from guideline-based therapy for febrile neutropenia in cancer patients and their effect on outcomes Temporal and geographic variation in the use of hematopoietic growth factors in older women receiving breast cancer chemotherapy: findings from a large population-based cohort Pharmacoeconomics of the myeloid growth factors: a critical and systematic review

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 171 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software